Patent 7812032 was granted and assigned to Abbott on October, 2010 by the United States Patent and Trademark Office.
A rapamycin analog composition includes a crystalline form of a rapamycin analog. The crystal can be a hydrate, dehydrate, solvate, or desolvate. The rapamycin analog can have a structure of Formula 1, which is optionally a prodrug, salt, derivative, or combination thereof: